TSE:5527 stock news
This page provides real-time market news, earnings updates, and company announcements related to property technologies, Inc. (TSE:5527).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-25 23:15 JST
What To Expect From Assured Guaranty's (AGO) Q4 Earnings
Finviz2026-02-25 03:33:06
Sun Communities (SUI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Finviz2026-02-25 04:33:45
Keefe Bruyette Raises its Price Target on The Travelers Companies, Inc. (TRV) to $340 and Maintains an Outperform Rating
Finviz2026-02-25 05:27:02
BofA Lowers its Price Target on The Progressive Corporation (PGR) to $315 from $329 and Maintains a Buy Rating
Finviz2026-02-25 05:45:05
TeraWulf (WULF) Climbs 12% Ahead of FY25 Earnings
Finviz2026-02-25 06:45:44
What Drove MDJM Ltd. (UOKA) Shares To Jump Over 26% After Hours
Finviz2026-02-25 07:09:08
Avista Corp. Reports 2025 Financial Results, Initiates 2026 Utility Earnings Guidance
Finviz2026-02-25 12:10:04
Starwood Property Trust: Fourth Quarter Earnings Overview
101 finance2026-02-25 12:33:45
Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested
Finviz2026-02-25 13:03:47
Prime Medicine to Participate in Upcoming Investor Conferences
Finviz2026-02-25 13:03:47
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
Finviz2026-02-25 13:03:47
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-25 13:03:49
Freshworks to Participate in Upcoming Investor Conferences
Finviz2026-02-25 13:03:48
Biopharmaceutical company Enveric Biosciences announced today that Gilgamesh Pharmaceuticals has officially withdrawn its post-grant review request for a patent previously filed against Enveric Biosciences.
老虎证券2026-02-25 13:24:30
N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
Finviz2026-02-25 13:34:28
Lowe's earnings beat expectations, sales grow over 10% against the trend
新浪财经2026-02-25 13:41:06
EverQuote to Present at the Raymond James Annual Institutional Investors Conference
Finviz2026-02-25 13:34:29
Data I/O's Security Strategy: Evaluating Its Standing Along the IoT Implementation S-Curve
101 finance2026-02-25 13:57:58
Strength Displayed by Heritage Insurance (HRTG): Will Its 17.9% Surge Lead to Further Gains?
101 finance2026-02-25 14:01:27
EverQuote at Raymond James: Assessing the Insurance Tech Play for Portfolio Rotation
101 finance2026-02-25 14:01:42
EverQuote at Raymond James: Assessing the Insurance Tech Play for Portfolio Rotation
101 finance2026-02-25 14:01:42
AIM ImmunoTech Announces Extension of Subscription Period of its Previously Announced Rights Offering to March 3, 2026
Finviz2026-02-25 14:03:11
2 Reasons to Appreciate CDNS and 1 Reason for Caution
101 finance2026-02-25 14:06:45
Newmark's In-Line Results: What's Already Priced In?
101 finance2026-02-25 14:07:02
TeraWulf (WULF) Climbs 12% Ahead of FY25 Earnings
Finviz2026-02-25 06:45:44
What Drove MDJM Ltd. (UOKA) Shares To Jump Over 26% After Hours
Finviz2026-02-25 07:09:08
Avista Corp. Reports 2025 Financial Results, Initiates 2026 Utility Earnings Guidance
Finviz2026-02-25 12:10:04
Starwood Property Trust: Fourth Quarter Earnings Overview
101 finance2026-02-25 12:33:45
Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested
Finviz2026-02-25 13:03:47
Prime Medicine to Participate in Upcoming Investor Conferences
Finviz2026-02-25 13:03:47
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
Finviz2026-02-25 13:03:47
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-25 13:03:49
Freshworks to Participate in Upcoming Investor Conferences
Finviz2026-02-25 13:03:48
Biopharmaceutical company Enveric Biosciences announced today that Gilgamesh Pharmaceuticals has officially withdrawn its post-grant review request for a patent previously filed against Enveric Biosciences.
老虎证券2026-02-25 13:24:30
N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
Finviz2026-02-25 13:34:28
Lowe's earnings beat expectations, sales grow over 10% against the trend
新浪财经2026-02-25 13:41:06
EverQuote to Present at the Raymond James Annual Institutional Investors Conference
Finviz2026-02-25 13:34:29
Data I/O's Security Strategy: Evaluating Its Standing Along the IoT Implementation S-Curve
101 finance2026-02-25 13:57:58
Strength Displayed by Heritage Insurance (HRTG): Will Its 17.9% Surge Lead to Further Gains?
101 finance2026-02-25 14:01:27
EverQuote at Raymond James: Assessing the Insurance Tech Play for Portfolio Rotation
101 finance2026-02-25 14:01:42
EverQuote at Raymond James: Assessing the Insurance Tech Play for Portfolio Rotation
101 finance2026-02-25 14:01:42
AIM ImmunoTech Announces Extension of Subscription Period of its Previously Announced Rights Offering to March 3, 2026
Finviz2026-02-25 14:03:11
2 Reasons to Appreciate CDNS and 1 Reason for Caution
101 finance2026-02-25 14:06:45
Newmark's In-Line Results: What's Already Priced In?
101 finance2026-02-25 14:07:02
TSE:5527 stock price change
On the last trading day, TSE:5527 stock closed at 728.00 JPY, with a price change of -2.54% for the day.
Trade stock perpsTSE:5527 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more